SCHEMBL31661644

SCHEMBL31661644

O=C(O)CCCCC(=O)Nc1ccc(Cl)cc1O

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.56
ALDH1A1 P00352 2/20 0.56
TDP1 Q9NUW8 3/20 0.56
GAA P10253 2/20 0.55
ALOX15 P16050 1/20 0.55
MAPK1 P28482 1/20 0.55
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
KDM4E B2RXH2 3/20 0.51
MAPT P10636 1/20 0.51
RAB9A P51151 2/20 0.49
CXCR2 P25025 1/20 0.47
NPC1 O15118 1/20 0.46
EGFR P00533 1/20 0.46
ERBB3 P21860 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5655283 1.00 POLB (0.56) POLBALDH1A1TDP1GAAALOX15
SCHEMBL13593325 0.98 POLB (0.55) POLBALDH1A1TDP1GAAALOX15
SCHEMBL13593333 0.98 POLB (0.55) POLBALDH1A1TDP1GAAALOX15
SCHEMBL31661769 0.88 POLB (0.69) POLBALDH1A1TDP1GAAALOX15
SCHEMBL7718043 0.88 POLB (0.69) POLBALDH1A1TDP1GAAALOX15
SCHEMBL7717051 0.88 POLB (0.69) POLBALDH1A1TDP1GAAALOX15
SCHEMBL5656576 0.88 POLB (0.69) POLBALDH1A1TDP1GAAALOX15
SCHEMBL3046406 0.88 POLB (0.69) POLBALDH1A1TDP1GAAALOX15
SCHEMBL7719057 0.86 POLB (0.71) POLBALDH1A1TDP1GAAALOX15
SCHEMBL7719074 0.82 GAA (0.76) POLBTDP1GAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO claimed
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO disclosed